AstraZeneca
Pfizer's $11-bn share repurchase ends chances of renewed bid for AstraZeneca
25 Oct 2014
US drugmaker Pfizer’s board yesterday authorised a new $11-billion share repurchase plan, which analysts say puts an end to speculations that it would renew its bid for British rival AstraZeneca
AstraZeneca India delisting under Sebi lens for cheating investors
25 Jun 2014
Sebi says it would take appropriate measures in order to protect the interest of retail investors in the delisting process
US FDA gives `fast-track’ status for AstraZeneca’s novel antibiotic for treatment of gonorrhea
04 Jun 2014
Pfizer drops AstarZeneca take over bid
28 May 2014
AstraZeneca rejects Pfizer’s third takeover offer
19 May 2014
AstraZeneca said that Pfizer’s tax-driven inversion structure, which is a key part of its proposal, has already been the subject of intense public and governmental scrutiny
.webp)
